Publication | Open Access
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
21
Citations
33
References
2021
Year
SOF/VEL plus RBV for 12 weeks is efficacious and well-tolerated for Child-Pugh B/C HCV-related cirrhosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1